BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 34397024)

  • 21. Early Follicular Phase Human Chorionic Gonadotropin Addition May Improve the Outcomes of
    Zhang C; Wu F; Wu Z; Sun B; Chen C; Qian W
    Front Endocrinol (Lausanne); 2021; 12():739773. PubMed ID: 34707571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GnRH agonist and hCG (dual trigger) versus hCG trigger for final follicular maturation: a double-blinded, randomized controlled study.
    Haas J; Bassil R; Samara N; Zilberberg E; Mehta C; Orvieto R; Casper RF
    Hum Reprod; 2020 Jul; 35(7):1648-1654. PubMed ID: 32563188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual trigger using recombinant HCG and gonadotropin-releasing hormone agonist improve oocyte maturity and embryo grading for normal responders in GnRH antagonist cycles: Randomized controlled trial.
    Ali SS; Elsenosy E; Sayed GH; Farghaly TA; Youssef AA; Badran E; Abbas AM; Abdelaleem AA
    J Gynecol Obstet Hum Reprod; 2020 May; 49(5):101728. PubMed ID: 32173633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reproductive Outcome After GnRH Agonist Triggering With Co-Administration of 1500 IU hCG on the Day of Oocyte Retrieval in High Responders: A Long-Term Retrospective Cohort Study.
    Abdulkhalikova D; Bokal EV; Stimpfel M; Ciglar P; Korosec S
    Front Endocrinol (Lausanne); 2022; 13():826411. PubMed ID: 35464066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin improves live birth rates in POSEIDON group 3 and 4 expected poor responders.
    Tulek F; Kahraman A; Demirel LC
    Gynecol Endocrinol; 2022 Sep; 38(9):731-735. PubMed ID: 35856433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual trigger of final oocyte maturation with a combination of GnRH agonist and hCG versus a hCG alone trigger in GnRH antagonist cycle for in vitro fertilization: A Systematic Review and Meta-analysis.
    Ding N; Liu X; Jian Q; Liang Z; Wang F
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():92-98. PubMed ID: 28957685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.
    Orvieto R
    J Ovarian Res; 2015 Nov; 8():69. PubMed ID: 26536862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does 'Dual Trigger' Increase Oocyte Maturation Rate?
    Ben-Haroush A; Sapir O; Salman L; Altman E; Garor R; Margalit T; Shufaro Y; Oron G
    J Obstet Gynaecol; 2020 Aug; 40(6):860-862. PubMed ID: 31790320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial.
    Engmann LL; Maslow BS; Kaye LA; Griffin DW; DiLuigi AJ; Schmidt DW; Grow DR; Nulsen JC; Benadiva CA
    J Ovarian Res; 2019 Jan; 12(1):8. PubMed ID: 30684970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles.
    Seval MM; Özmen B; Atabekoğlu C; Şükür YE; Şimşir C; Kan Ö; Sönmezer M
    J Obstet Gynaecol Res; 2016 Sep; 42(9):1146-51. PubMed ID: 27199084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing the efficacy of urinary and recombinant hCG on oocyte/follicle ratio to trigger ovulation in women undergoing intracytoplasmic sperm injection cycles: a randomized controlled trial.
    Madani T; Mohammadi Yeganeh L; Ezabadi Z; Hasani F; Chehrazi M
    J Assist Reprod Genet; 2013 Feb; 30(2):239-45. PubMed ID: 23274511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves oocyte yield in normal responders on GnRH-antagonist cycles.
    Albeitawi S; Marar EA; Reshoud FA; Hamadneh J; Hamza R; Alhasan G; Omeish H; Vigano P
    JBRA Assist Reprod; 2022 Jan; 26(1):28-32. PubMed ID: 34463444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GnRH agonist in association with hCG versus hCG alone for final oocyte maturation triggering in GnRH antagonist cycles.
    Oliveira CM; Oliveira CAM; Fonseca LL; Souza KRR; Radaelli MRM
    JBRA Assist Reprod; 2021 Apr; 25(2):246-251. PubMed ID: 33507721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual trigger improves the pregnancy rate in fresh in vitro fertilization (IVF) cycles compared with the human chorionic gonadotropin (hCG) trigger: a systematic review and meta-analysis of randomized trials.
    Hsia LH; Lee TH; Lin YH; Huang YY; Chang HJ; Liu YL
    J Assist Reprod Genet; 2023 Sep; 40(9):2063-2077. PubMed ID: 37466846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Final Oocyte Maturation in Assisted Reproduction with Human Chorionic Gonadotropin and Gonadotropin-releasing Hormone agonist (Dual Trigger).
    Oliveira SA; Calsavara VF; Cortés GC
    JBRA Assist Reprod; 2016 Dec; 20(4):246-250. PubMed ID: 28050961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation.
    Liang IT; Huang HY; Wu HM; Wang HS; Yu HT; Huang SY; Chang CL; Soong YK
    Taiwan J Obstet Gynecol; 2015 Oct; 54(5):583-7. PubMed ID: 26522115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization.
    Kim CH; Ahn JW; You RM; Kim SH; Chae HD; Kang BM
    J Reprod Med; 2014; 59(1-2):63-8. PubMed ID: 24597289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes.
    Zilberberg E; Haas J; Dar S; Kedem A; Machtinger R; Orvieto R
    Gynecol Endocrinol; 2015 Feb; 31(2):145-7. PubMed ID: 25385007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual trigger of final oocyte maturation in poor ovarian responders undergoing IVF/ICSI cycles.
    Zhang J; Wang Y; Mao X; Chen Q; Hong Q; Cai R; Zhang S; Kuang Y
    Reprod Biomed Online; 2017 Dec; 35(6):701-707. PubMed ID: 28993105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual triggering with GnRH agonist plus hCG versus triggering with hCG alone for IVF/ICSI outcome in GnRH antagonist cycles: a systematic review and meta-analysis.
    Chen CH; Tzeng CR; Wang PH; Liu WM; Chang HY; Chen HH; Chen CH
    Arch Gynecol Obstet; 2018 Jul; 298(1):17-26. PubMed ID: 29600322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.